Literature DB >> 21700087

Reconstituted high-density lipoprotein shortens cardiac repolarization.

Hester M Den Ruijter1, Remco Franssen, Arie O Verkerk, Diederik F van Wijk, Stefan F Vaessen, Adriaan G Holleboom, Johannes H Levels, Tobias Opthof, Rattapong Sungnoon, Erik S Stroes, Jan Albert Kuivenhoven, Ruben Coronel.   

Abstract

OBJECTIVES: We hypothesize that increasing high-density lipoprotein cholesterol (HDL-C) shortens cardiac repolarization.
BACKGROUND: HDL-C is inversely associated with sudden death. The relation between HDL-C and repolarization of the heart is unexplored.
METHODS: HDL-C was elevated with reconstituted high-density lipoprotein (rHDL). Cardiac repolarization was studied by recording cardiac transmembrane potentials with the patch clamp technique from isolated rabbit cardiomyocytes that were superfused with rHDL. Infusions with rHDL (40 mg/kg body weight) were performed in dyslipidemic patients and healthy volunteers. Electrocardiograms were recorded to assess cardiac repolarization before and 24 h after infusion with rHDL.
RESULTS: rHDL as well as purified human apolipoprotein AI shortened repolarization of isolated rabbit cardiomyocytes by ∼25% (p < 0.05). rHDL infusion shortened the heart rate-corrected QT interval on surface electrocardiograms in all participants (p < 0.001).
CONCLUSIONS: rHDL shortens cardiac repolarization. These data provide evidence for a novel mechanism of HDL infusion that may contribute to reduction of sudden cardiac death.
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21700087     DOI: 10.1016/j.jacc.2010.11.072

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  10 in total

1.  Reconstituted high-density lipoprotein therapies: a cause for optimism.

Authors:  Ali Javaheri; Daniel M Kolansky; Marina Cuchel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-09       Impact factor: 8.311

2.  The ratio of high-density lipoprotein cholesterol to apolipoprotein A-I predicts myocardial injury following elective percutaneous coronary intervention.

Authors:  Xiao-Lin Li; Jian-Jun Li; Yuan-Lin Guo; Cheng-Gang Zhu; Ping Qing; Na-Qiong Wu; Bo Xu; Run-Lin Gao
Journal:  Clin Cardiol       Date:  2014-08-11       Impact factor: 2.882

3.  Predicted gene expression in ancestrally diverse populations leads to discovery of susceptibility loci for lifestyle and cardiometabolic traits.

Authors:  Heather M Highland; Genevieve L Wojcik; Mariaelisa Graff; Katherine K Nishimura; Chani J Hodonsky; Antoine R Baldassari; Alanna C Cote; Iona Cheng; Christopher R Gignoux; Ran Tao; Yuqing Li; Eric Boerwinkle; Myriam Fornage; Jeffrey Haessler; Lucia A Hindorff; Yao Hu; Anne E Justice; Bridget M Lin; Danyu Lin; Daniel O Stram; Christopher A Haiman; Charles Kooperberg; Loic Le Marchand; Tara C Matise; Eimear E Kenny; Christopher S Carlson; Eli A Stahl; Christy L Avery; Kari E North; Jose Luis Ambite; Steven Buyske; Ruth J Loos; Ulrike Peters; Kristin L Young; Stephanie A Bien; Laura M Huckins
Journal:  Am J Hum Genet       Date:  2022-03-08       Impact factor: 11.043

4.  Lipid lowering and HDL raising gene transfer increase endothelial progenitor cells, enhance myocardial vascularity, and improve diastolic function.

Authors:  Stephanie C Gordts; Eline Van Craeyveld; Ilayaraja Muthuramu; Neha Singh; Frank Jacobs; Bart De Geest
Journal:  PLoS One       Date:  2012-10-04       Impact factor: 3.240

5.  Nonalcoholic Fatty Liver Disease Is Associated With QT Prolongation in the General Population.

Authors:  Chi-Sheng Hung; Ping-Huei Tseng; Chia-Hung Tu; Chien-Chuan Chen; Wei-Chih Liao; Yi-Chia Lee; Han-Mo Chiu; Hung-Ju Lin; Yi-Lwun Ho; Wei-Shiung Yang; Ming-Shiang Wu; Ming-Fong Chen
Journal:  J Am Heart Assoc       Date:  2015-07-21       Impact factor: 5.501

6.  Selective HDL-Raising Human Apo A-I Gene Therapy Counteracts Cardiac Hypertrophy, Reduces Myocardial Fibrosis, and Improves Cardiac Function in Mice with Chronic Pressure Overload.

Authors:  Ruhul Amin; Ilayaraja Muthuramu; Joseph Pierre Aboumsallem; Mudit Mishra; Frank Jacobs; Bart De Geest
Journal:  Int J Mol Sci       Date:  2017-09-20       Impact factor: 5.923

Review 7.  HDL Composition, Heart Failure, and Its Comorbidities.

Authors:  Ahmed Diab; Carla Valenzuela Ripoll; Zhen Guo; Ali Javaheri
Journal:  Front Cardiovasc Med       Date:  2022-03-08

8.  HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research.

Authors:  Anand Rohatgi; Marit Westerterp; Arnold von Eckardstein; Alan Remaley; Kerry-Anne Rye
Journal:  Circulation       Date:  2021-06-07       Impact factor: 39.918

9.  Human electronegative low-density lipoprotein modulates cardiac repolarization via LOX-1-mediated alteration of sarcolemmal ion channels.

Authors:  An-Sheng Lee; Yutao Xi; Chin-Hu Lai; Wei-Yu Chen; Hsien-Yu Peng; Hua-Chen Chan; Chu-Huang Chen; Kuan-Cheng Chang
Journal:  Sci Rep       Date:  2017-09-07       Impact factor: 4.379

10.  Association Between HDL Cholesterol and QTc Interval: A Population-Based Epidemiological Study.

Authors:  Rosaria Del Giorno; Sofia Gabutti; Chiara Troiani; Kevyn Stefanelli; Raffaele Falciano; Elisa Graziano; Tommaso Rochat Negro; Luca Gabutti
Journal:  J Clin Med       Date:  2019-09-23       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.